Area of research
Hematology · Rheumatology
Research interest
Research interests include Otitis Media and Relapsing Polychondritis, Vasculitis and related conditions, Platelet Disorders and Treatments, and Blood groups and transfusion.
Efficacy and safety of azacitidine for VEXAS syndrome: a large-scale retrospective study from FRENVEX.
Impaired cytotoxic function and exhausted phenotype of natural killer cells in VEXAS syndrome.
IRF4 haploinsufficiency in a multiplex family with Whipple’s disease
Efficacy and safety of targeted therapies in VEXAS syndrome: retrospective study from the FRENVEX
VEXAS syndrome is characterized by inflammasome activation and monocyte dysregulation.
Serious infections in patients with VEXAS syndrome: data from the French VEXAS registry
Activated phosphoinositide 3-kinase δ syndrome: Update from the ESID Registry and comparison with other autoimmune-lymphoproliferative inborn errors of immunity
Treatment strategy for acquired pure red cell aplasia: a systematic review and meta-analysis
Treatment strategy for acquired pure red cell aplasia: a systematic review and meta-analysis.
Ruxolitinib is more effective than other JAK inhibitors to treat VEXAS syndrome: a retrospective multicenter study
Ruxolitinib is more effective than other JAK inhibitors to treat VEXAS syndrome: a retrospective multicenter study.
Clinical and pathological features of cutaneous manifestations in VEXAS syndrome: A multicenter retrospective study of 59 cases
Azacitidine for patients with Vacuoles, E1 Enzyme, X‐linked, Autoinflammatory, Somatic syndrome (VEXAS) and myelodysplastic syndrome: data from the French VEXAS registry
Hematopoietic Cell Transplantation Cures Adenosine Deaminase 2 Deficiency: Report on 30 Patients
Immune thrombocytopenia with clinical significance in systemic lupus erythematosus: a retrospective cohort study of 90 patients
DADA2 diagnosed in adulthood versus childhood: A comparative study on 306 patients including a systematic literature review and 12 French cases
Temporal Arteritis Revealing Antineutrophil Cytoplasmic Antibody–Associated Vasculitides: A Case–Control Study
Long‐term safety and efficacy of rituximab in 248 adults with immune thrombocytopenia: Results at 5 years from the French prospective registry ITP‐ritux
Characteristics, risk factors and management of venous thromboembolism in immune thrombocytopenia: a retrospective multicentre study.
Computed and Subjective Blue Scleral Color Analysis as a Diagnostic Tool for Iron Deficiency: A Pilot Study.
Characteristics, outcome, and response to therapy of multirefractory chronic immune thrombocytopenia
Clinical features and prognostic factors of spinal cord sarcoidosis: a multicenter observational study of 20 BIOPSY-PROVEN patients
Pituitary Involvement in Granulomatosis With Polyangiitis
Safety and efficacy of rituximab in adult immune thrombocytopenia: results from a prospective registry including 248 patients
Eosinophilic granulomatosis with polyangiitis (Churg‐Strauss): Clinical characteristics and long‐term followup of the 383 patients enrolled in the French Vasculitis Study Group cohort